ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Hodgkin Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Follicular Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Recurrence

Lymphoma trials near Dallas, TX, USA:

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

in participants with relapsed/refractory (R/R) peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), follicular helper T-cell lymphomas...

Enrolling
Lymphoma, T-Cell
Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
Drug: Pralatrexate
Drug: Belinostat

Phase 3

Corvus Pharmaceuticals
Corvus Pharmaceuticals

Dallas, Texas, United States and 36 other locations

chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....

Enrolling
Relapsed Non-Hodgkin Lymphoma
Large B-cell Lymphoma
Drug: Rondecabtagene autoleucel (ronde-cel)
Drug: Fludarabine

Phase 1, Phase 2

Lyell Immunopharma

Dallas, Texas, United States and 34 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Dallas, Texas, United States and 28 other locations

medical needs, such as Human Immunodeficiency Virus (HIV)-associated lymphoma, primary and secondary central nervous system (CNS) lymphoma...

Enrolling
Lymphoma, Non-Hodgkins
Refractory B-Cell Non-Hodgkin Lymphoma
Biological: EB103

Phase 1, Phase 2

Estrella Immunopharma, Inc.

Dallas, Texas, United States and 4 other locations

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Dallas, Texas, United States and 71 other locations

The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...

Active, not recruiting
Refractory B-Cell Non-Hodgkin Lymphoma
Relapsed B-Cell Non-Hodgkin Lymphoma
Drug: Loncastuximab Tesirine
Drug: Polatuzumab Vedotin

Phase 1

ADC Therapeutics

Dallas, Texas, United States and 39 other locations

with acute lymphoblastic leukemia (ALL) and acute lymphoblastic lymphoma (LLy).Primary Therapeutic Objectives:* To improve the event-free su...

Active, not recruiting
Acute Lymphoblastic Lymphoma
Acute Lymphoblastic Leukemia
Drug: Asparaginase Erwinia chrysanthemi (recombinant)-rywn
Drug: Thioguanine

Phase 2, Phase 3

St. Jude Children's Research Hospital
St. Jude Children's Research Hospital

Fort Worth, Texas, United States and 7 other locations

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Fludarabine
Drug: JCAR017

Phase 2

Celgene
Celgene

Dallas, Texas, United States and 48 other locations

This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...

Active, not recruiting
Lymphoma, Mantle-Cell
Drug: Ibrutinib
Drug: Pirtobrutinib

Phase 3

Loxo Oncology
Loxo Oncology

Bedford, Texas, United States and 197 other locations

The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...

Active, not recruiting
Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)
Small Lymphocytic Lymphoma (SLL)
Biological: Epcoritamab

Phase 1, Phase 2

Genmab
Genmab

Dallas, Texas, United States and 84 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems